The Latest in Rheumatology

Internal Medicine News

Frozen sections can guide biopsies for giant cell arteritis, but are they feasible?

February 23, 2021

Rheumatology

Internal Medicine News

Romosozumab may not increase cardiovascular risk after all

February 17, 2021

Internal Medicine News

Outcomes have improved for PAH in connective tissue disease

February 17, 2021

Internal Medicine News

Consider home subcutaneous immune globulin for refractory dermatomyositis

February 17, 2021

Internal Medicine News

Tocilizumab may improve lung function in early systemic sclerosis

February 17, 2021

Internal Medicine News

Checkpoint inhibitors’ ‘big picture’ safety shown with preexisting autoimmune diseases

February 16, 2021

Internal Medicine News

Cumulative exposure to high-potency topical steroid doses drives osteoporosis fractures

February 16, 2021

Internal Medicine News

TNF inhibitors may slow spinal progression in axial spondyloarthritis

February 10, 2021

Rheumatology

Internal Medicine News

Rheumatologic disease activity an important influencer of COVID-19 death risk

February 5, 2021

Internal Medicine News

FDA alert confirms heart and cancer risks with tofacitinib (Xeljanz)

February 5, 2021

Internal Medicine News

COVID-19: Another study links colchicine to better results

February 4, 2021

Internal Medicine News

Dan Kastner wins Crafoord Prize in Polyarthritis

February 3, 2021

Internal Medicine News

Patients with early arthritis may need tailored treatments

February 2, 2021

Rheumatology

Internal Medicine News

Tofacitinib for RA misses the mark in safety study

February 1, 2021

Internal Medicine News

Meta-analysis finds much less lupus than expected

January 29, 2021